Feed EVO
EV

Evotec SE

EVO · NASDAQ

$1.58 +1.94% (+$0.03)
1M -18.52%
Market Cap 490.2M €
P/E Ratio -
Div. Yield -
ROE 26.85%
Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/S 0.68x
P/B 0.74x
P/E N/A
Growth
16 /100
Declining
Rev. growth 0.26%
Book val. growth 11.84%
EPS growth N/A
Profitability
1 /100
Weak
Gross margin 10.34%
Net margin 27.78%
Op. margin 17.89%
Quality
6 /100
Poor
ROIC 10.41%
ROE 26.85%
ROA 12.70%
Debt
54 /100
Moderate
Debt/Equity 0.71x
Current ratio 2.33x
Int. coverage -15.75x
Stability
45 /100
Moderate
Beta 1.26x
Rev. volatility 4.71%
EPS volatility 112.60%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o EVO
Online

O podjetju

Evotec SE (EVT) is a German pharmaceutical company focused on drug research and development. The company provides services to pharmaceutical and biotechnology firms in the areas of drug discovery, testing, and drug development. Evotec collaborates with various research institutions and pharmaceutical companies worldwide to identify and develop new drugs for different diseases. The company specializes in areas such as oncology, neurology, metabolic disorders, and infectious diseases. Evotec has a long history of research and innovation in the pharmaceutical industry, and its technologies and expertise are highly regarded in the world of medical research. Evotec SE (EVT) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company with a significant role in discovering new drugs and therapeutic approaches.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Christian Wojczewski

Employees

4,553

Headquarters

Hamburg

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

43d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.